Fig. 2From: A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancerSubnetworks constructed in this study as visualized using Cytoscape. A Apigenin 10M, B Genistein 3M, C Genistein 10M, D Resveratrol 150mM, E Resveratrol 250mM, F ER + breast cancer. Only the first 20 genes with the highest betweenness centrality are shown for enhanced visualizationBack to article page